The European Molecular Biology Organisation (EMBO) is made up of over 1500 leading researchers from across Europe with a focus on promoting excellence in the life sciences. EMBO's primary aim is to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment in which scientists can achieve their best work.

Election to EMBO membership is an internationally recognised honour within the research field and 66 EMBO Members and Associate Members have been awarded Nobel Prizes in the past. Originally from Switzerland, Professor Meier studied at the University of Zurich before moving to London. He was one of the first team leaders at the Breakthrough Toby Robins Breast Cancer Research Centre when he arrived in 2000.

Just one of the notable contributions he has made to Breakthrough's research work is the identification of a complex of proteins called the ‘ripoptosome’ which plays an important role in the mechanism by which chemotherapy kills cancer cells.  Understanding these mechanisms is essential in order to improve the effectiveness of chemotherapy and to develop effective drug combinations for breast cancer treatment.